Bristol-Myers Squibb Co (BMY)

NYSE · Pharmaceuticals

66.98
+0.93 (+1.41%)
Updated Aug 19, 4:30 PM ET
AI Rating
Buy
Overall Score
70
Trend
72
Momentum
59
Risk
83

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 23, 2026 120 sessions Aug 14, 2026

AI Analysis

Bristol-Myers Squibb Co is trading at $66.98, up 1.41% on the session. The 50 day average sits at $59.46 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 56.7, which reads as strong, and MACD is bearish crossover. Volume is below average.

The nearest support is around $63.20 with resistance near $68.10, so that band frames the current range. Average daily movement is roughly $1.68, or about 2.5% of the share price, which is what any stop placement has to allow for. The overall health score of 70 out of 100 combines a trend score of 72, momentum of 59 and a risk score of 83.

Technical indicators

RSI (14)
56.7
strong
MACD
1.397
bearish crossover
SMA 20
63.46
SMA 50
59.46
SMA 200
--
unknown
ATR (14)
1.68
avg daily range
Support
63.20
Resistance
68.10
Volume vs 20d
0.60x
below average
Volatility
22.0%
annualised
1 month
+8.70%
3 months
+13.19%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.